Preparing for a Life Sciences IPO in Today’s Market

Michael Feuz, Ron Melling, Mark Shannon, Tom Shoemaker, Ryan Walker
3/12/2026

Taking a life sciences company public requires significant preparation. This webinar explores today’s IPO landscape, key readiness considerations, and common financial reporting risks facing life sciences companies.

In this session, Crowe professionals and industry economists examine what it takes to prepare a life sciences organization for an initial public offering in today’s evolving market. Topics include:

  • Current economic and capital markets trends affecting IPO activity
  • Aligning scientific, clinical, and commercial strategies with a compelling equity story
  • Scaling operations and governance for public company readiness
  • Common financial reporting risks and how to mitigate them
Life sciences audit services
We understand the life cycle of life sciences companies, the full breadth of the life sciences ecosystem, and how to meet your needs.

Contact us


Ron-Melling-225
Ron Melling
Partner, Audit & Assurance
Mark Shannon
Mark Shannon
Partner, National Office
Tom Shoemaker at Crowe LLP.
Tom Shoemaker
Partner, Audit & Assurance
Ryan Walker
Ryan J. Walker
Partner, National Office